Prof. Masayoshi Yamaguchi

University of Hawaii Cancer Center, University of Hawaii at Manoa, USA

Email: [email protected]

Qualifications

1976 Ph.D., Pharmaceutical Sciences, Shizuoka College of Pharmacy

1973 M.S., Pharmaceutical Sciences, Shizuoka College of Pharmacy

1971 B.S., Pharmaceutical Sciences, Shizuoka College of Pharmacy

Publications (Selected)

1. Kondo, S., Kojima, K., Airi, H., et al. (2025). Effect of Imeglimin on Periodontitis in Streptozotocin-Induced Diabetic Rats. Diabetes, 74(Suppl_1), Article 864-P.
2. Murata, T., Yamaguchi, M., Kohno, S., et al. (2018). Regucalcin confers resistance to amyloid-β toxicity in neuronally differentiated PC12 cells. FEBS Open Bio, 8(3), 349-360.
3. Yamaguchi, M. (2015). The potential role of regucalcin in kidney cell regulation: Involvement in renal failure. International Journal of Molecular Medicine, 36(5), 1191-1199.
4. Yamaguchi, M. (2016). The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases. Molecular and Cellular Biochemistry, 421(1-2), 193-203.
5. Yamaguchi, M. (2025). The advanced role of the transcription factor RGPR-p117 in cell regulation: Its involvement in transcription, cell growth, and lipid metabolism. International Journal of Biological Macromolecules, 327(Pt 2), Article 147359.
6. Yamaguchi, M., & Hankinson, O. (2018). 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses the growth of human liver cancer HepG2 cells in vitro: Involvement of cell signaling factors. International Journal of Oncology, 53(4), 1657-1666.
7. Yamaguchi, M., & Hankinson, O. (2019). 2,3,7,8-tetrachlorodibenzo-p-dioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling. International Journal of Oncology, 54(4), 1422-1432.
8. Yamaguchi, M., & Levy, R. M. (2016a). β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro. Experimental and Therapeutic Medicine, 12(6), 3602-3606.
9. Yamaguchi, M., & Levy, R. M. (2016b). The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro. International Journal of Molecular Medicine, 38(6), 1940-1946.
10. Yamaguchi, M., & Levy, R. M. (2017). Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro. Experimental and Therapeutic Medicine, 14(2), 1769-1774.
11. Yamaguchi, M., & Levy, R. M. (2019). The combination of catechin, baicalin and -caryophyllene potentially suppresses the production of inflammatory cytokines in mouse macrophages in vitro. Experimental and Therapeutic Medicine, 17(5), 4312-4318.
12. Yamaguchi, M., & Murata, T. (2015a). Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro. Molecular Medicine Reports, 12(5), 7801-7805.
13. Yamaguchi, M., & Murata, T. (2016). Potential suppressive effects of gentian violet on human breast cancer MDA-MB-231 cells in vitro: Comparison with gemcitabine. Oncology Letters, 12(2), 1605-1609.
14. Yamaguchi, M., & Murata, T. (2018a). Exogenous regucalcin suppresses the growth of human liver cancer HepG2 cells in vitro. Oncology Reports, 39(6), 2924-2930.
15. Yamaguchi, M., & Murata, T. (2018b). Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro (vol 12, pg 7801, 2015). Molecular Medicine Reports, 17(2), 3432.
16. Yamaguchi, M., & Murata, T. (2020). Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells. Tissue & Cell, 67, Article 101447.
17. Yamaguchi, M., & Osuka, S. (2018). Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in vitro. International Journal of Oncology, 53(3), 1313-1322.
18. Yamaguchi, M., Murata, T., & El-Rayes, B. F. (2015). The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine. Oncology Reports, 34(6), 3304-3310.
19. Yamaguchi, M., Murata, T., Shoji, M., et al. (2015). The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases. International Journal of Oncology, 47(4), 1563-1571.
20. Yamaguchi, M., Osuka, S., Hankinson, O., et al. (2019). Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro. International Journal of Oncology, 54(1), 188-198.

Profile Details
https://www.uhcancercenter.org/yamaguchi-masayoshi
https://www.researchgate.net/profile/Masayoshi-Yamaguchi
https://scholar.google.com/citations?user=PG8yrnkAAAAJ&hl=ja

WOS ResearcherID: MVF-8200-2025